Cardiotoxicity in Patients With Lung Cancer Receiving Thoracic Radiotherapy and Immune-Checkpoint Therapy

被引：0
|
作者：
Son, C. [1 ]
Moey, M. [2 ]
Naqash, A. [3 ]
Walker, P. [4 ]
Peach, M. S. [5 ]
Ju, A. W. [5 ]
机构：
[1] East Carolina Univ, Brody Sch Med, Greenville, NC 27858 USA
[2] East Carolina Univ, Dept Cardiovasc Sci, Brody Sch Med, Greenville, NC 27858 USA
[3] East Carolina Univ, Brody Sch Med, Dept Hematol Oncol, Greenville, NC 27858 USA
[4] NCI, Affiliat Div Canc Treatment & Diag, Bethesda, MD 20892 USA
[5] East Carolina Univ, Brody Sch Med, Dept Radiat Oncol, Greenville, NC 27858 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2467
引用
收藏
页码：E235 / E236
页数：2
相关论文
共 50 条
  • [21] Emerging concern of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy
    Fujita, Kohei
    Kanai, Osamu
    Kim, Young Hak
    Yoshida, Hironori
    Mio, Tadashi
    Hirai, Toyohiro
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [22] Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy
    Fujita, Kohei
    Kim, Young Hak
    Kanai, Osamu
    Yoshida, Hironori
    Mio, Tadashi
    Hirai, Toyohiro
    RESPIRATORY MEDICINE, 2019, 146 : 66 - 70
  • [23] Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy
    Son, Christine
    Moey, Melissa Y. Y.
    Walker, Paul R.
    Naqash, Abdul R.
    Peach, Matthew Sean
    Ju, Andrew W.
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [24] Safety of combining radiotherapy with immune-checkpoint inhibition
    Hwang, William L.
    Pike, Luke R. G.
    Royce, Trevor J.
    Mahal, Brandon A.
    Loeffler, Jay S.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (08) : 477 - 494
  • [25] Association Between Efficacy and irAEs in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immune-Checkpoint Inhibitors
    Riudavets, M.
    Mosquera, J.
    Garcia Campelo, R.
    Serra, J.
    Anguera, G.
    Gallardo, P.
    Sullivan, I. G.
    Barba, A.
    Majem, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S446 - S447
  • [26] Potential New Immune-Checkpoint Inhibitor Partner for Lung Cancer
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (10): : 901 - 901
  • [27] Economic analyses of immune-checkpoint inhibitors to treat lung cancer
    Vergnenegre, Alain
    Chouaid, Christos
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (03) : 365 - 371
  • [28] Severe cardiotoxicity in 2 patients with thymoma receiving immune checkpoint inhibitor therapy: A case report
    Liu, Shiwei
    Ma, Guikai
    Wang, Hui
    Yu, Guohua
    Chen, Jun
    Song, Wenjing
    MEDICINE, 2022, 101 (46) : E31873
  • [29] Safety of combining radiotherapy with immune-checkpoint inhibition
    William L. Hwang
    Luke R. G. Pike
    Trevor J. Royce
    Brandon A. Mahal
    Jay S. Loeffler
    Nature Reviews Clinical Oncology, 2018, 15 : 477 - 494
  • [30] Incidence of thyroid test function abnormalities in patients receiving immune-checkpoint inhibitors for cancer treatment
    Patel, Nisha
    Oury, Anais
    Daniels, Gregory
    Bazhenova, Lyudmila
    Patel, Sandip
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345